
Zynex ZYXI
Quarterly report 2025-Q3
added 11-17-2025
Zynex Interest Expense 2011-2026 | ZYXI
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Zynex
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -440 K | -95 K | -19 K | -5 K | 154 K | 1.45 M | 352 K | 503 K | 536 K | 607 K | 435 K | 460 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.45 M | -440 K | 328 K |
Quarterly Interest Expense Zynex
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | -512 K | - | -327 K | -317 K | -84 K | - | -106 K | -115 K | -124 K | - | -18 K | -45 K | -9 K | - | -5 K | -5 K | -4 K | - | 1 K | - | - | - | 1 K | 37 K | 115 K | - | 691 K | 394 K | 121 K | - | 90 K | 77 K | 94 K | - | 98 K | 138 K | 132 K | - | 169 K | 144 K | 158 K | - | 136 K | 214 K | 130 K | - | 119 K | 81 K | 93 K | - | 87 K | 80 K | 58 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 691 K | -512 K | 47 K |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aethlon Medical
AEMD
|
10.1 K | $ 2.21 | 3.27 % | $ 3.45 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 10.61 | 1.82 % | $ 1.43 B | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
Butterfly Network
BFLY
|
-13 K | $ 4.22 | 7.66 % | $ 893 M | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 12.88 | 2.18 % | $ 1.93 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
Cognyte Software Ltd.
CGNT
|
-1.61 M | $ 8.38 | - | $ 602 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 71.53 | 2.49 % | $ 106 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 37.2 | -0.53 % | $ 1.15 B | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 4.07 | 2.73 % | $ 152 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Establishment Labs Holdings
ESTA
|
5.82 M | $ 65.28 | 2.84 % | $ 1.93 B | ||
|
Cutera
CUTR
|
-244 K | - | -10.19 % | $ 1.99 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
ClearPoint Neuro
CLPT
|
-40 K | $ 11.22 | 1.68 % | $ 303 M | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.43 | 0.05 % | $ 121 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.21 | 0.68 % | $ 1.34 M | ||
|
Abbott Laboratories
ABT
|
548 M | $ 111.3 | 1.23 % | $ 194 B | ||
|
Delcath Systems
DCTH
|
-70 K | $ 9.85 | 0.41 % | $ 353 M | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 269.14 | 3.09 % | $ 7.59 B | ||
|
LivaNova PLC
LIVN
|
664 K | $ 63.17 | 2.83 % | $ 3.45 B | ||
|
Integra LifeSciences Holdings Corporation
IART
|
3.94 M | $ 9.22 | 2.33 % | $ 710 M | ||
|
MiMedx Group
MDXG
|
-558 K | $ 4.43 | 0.34 % | $ 655 M | ||
|
AxoGen
AXGN
|
167 K | $ 32.73 | -0.33 % | $ 1.51 B | ||
|
Align Technology
ALGN
|
7.68 M | $ 177.7 | 4.87 % | $ 13.3 B | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 33.88 | 3.4 % | $ 5.05 K | ||
|
BioSig Technologies
BSGM
|
23 K | - | 37.08 % | $ 85.7 M | ||
|
Apyx Medical Corporation
APYX
|
2.48 M | $ 3.81 | 3.81 % | $ 157 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 17.34 | 1.34 % | $ 407 M | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 86.55 | 2.89 % | $ 3.01 B |